(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 71.29%45.82M | 108.06%201.11M | 114.97%60.33M | 663.64%54.23M | 38.31%59.8M | 46.51%26.75M | -8.47%96.66M | 27.23%28.06M | -74.99%7.1M | 47.33%43.24M |
Net income from continuing operations | -122.16%-3.64M | 96.16%85.03M | -17.25%12M | 1,266.73%23.41M | 115.21%33.2M | 40.24%16.41M | -25.52%43.34M | -1.00%14.5M | -88.60%1.71M | 29.81%15.43M |
Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.24M | ---- |
Depreciation and amortization | 18.34%18M | 60.12%76.97M | 88.33%21.16M | 120.91%24.86M | 20.41%15.74M | 21.61%15.21M | 25.07%48.07M | -21.85%11.24M | 26.13%11.25M | 64.09%13.07M |
Asset impairment expenditure | 230.09%415K | 128.53%10.7M | 718.97%11.48M | --0 | --0 | ---319K | --4.68M | --1.4M | --3.28M | --0 |
Remuneration paid in stock | 22.18%606K | -16.82%2.13M | -82.24%520K | 201.66%552K | 166.91%558K | -50.70%496K | -28.62%2.56M | 510.00%2.93M | -212.19%-543K | -147.28%-834K |
Deferred tax | 310.50%4.18M | -69.68%3.02M | -148.09%-3.73M | 25.89%603K | 830.13%5.13M | -11.93%1.02M | 10.87%9.95M | 982.15%7.76M | -70.56%479K | -83.94%551K |
Other non cashItems | 272.27%3.54M | 545.19%1.54M | -128.57%-200K | 126.60%404K | -39.40%386K | 126.13%952K | -69.97%239K | 152.71%700K | -5,976.00%-1.52M | 70.32%637K |
Change In working capital | 423.46%22.7M | 278.40%21.73M | 370.52%19.56M | 140.76%4.4M | -66.69%4.79M | 17.77%-7.02M | -178.63%-12.18M | 10.80%-7.23M | -566.55%-10.8M | 266.14%14.38M |
-Change in receivables | 103.32%2.57M | -48.82%-3.97M | 2,585.34%3.12M | -548.68%-7.62M | 78.41%-723K | -27.44%1.26M | 34.13%-2.67M | -88.86%116K | -193.33%-1.18M | 49.93%-3.35M |
-Change in inventory | 602.41%7M | 124.75%3.38M | 262.23%6.33M | 98.35%-168K | -302.63%-3.78M | 168.83%996K | -189.71%-13.65M | 36.22%-3.9M | -177.49%-10.17M | -61.89%1.86M |
-Change in payables and accrued expense | -170.92%-27.75M | 357.30%21.34M | 722.41%9.78M | 2,006.35%12.93M | -42.50%8.88M | -4.42%-10.24M | 61.77%4.67M | 61.64%-1.57M | -84.15%614K | 135.78%15.43M |
-Change in other working capital | 4,137.41%40.89M | 284.25%971K | 117.93%336K | -1,043.08%-743K | -4.62%413K | -1.43%965K | -135.06%-527K | -275.96%-1.87M | -107.68%-65K | 152.80%433K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 71.29%45.82M | 108.06%201.11M | 114.97%60.33M | 663.64%54.23M | 38.31%59.8M | 46.52%26.75M | -8.47%96.66M | 25.35%28.06M | -74.94%7.1M | 47.33%43.24M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -187.12%-82.2M | -39.89%-187.06M | -100.36%-76.63M | 12.32%-37.93M | -50.19%-43.87M | -24.44%-28.63M | -60.37%-133.72M | -127.78%-38.25M | -95.49%-43.26M | -22.72%-29.21M |
Capital expenditure reported | -217.93%-91.02M | -8.03%-157.92M | -24.15%-47.48M | 12.32%-37.93M | -23.43%-43.87M | 1.71%-28.63M | -68.26%-146.18M | -115.42%-38.25M | -85.61%-43.26M | -46.92%-35.54M |
Net business purchase and sale | --8.82M | --0 | --0 | --0 | --0 | --0 | 133.58%7.21M | --0 | --0 | --0 |
Net investment purchase and sale | ---- | ---29.14M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | 1,199.26%5.25M | --0 | ---- | 1,524.10%6.33M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -187.12%-82.2M | -39.89%-187.06M | -100.36%-76.63M | 12.32%-37.93M | -50.19%-43.87M | -24.44%-28.63M | -60.37%-133.72M | -127.78%-38.25M | -95.49%-43.26M | -22.72%-29.21M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 30.88%4.84M | 2.96%15.56M | 93.62%5.1M | -47.20%4.16M | 162.93%2.6M | 2.52%3.7M | 398.71%15.12M | 87,833.33%2.63M | 1,901.02%7.88M | -60.10%990K |
Net issuance payments of debt | -98.63%38K | -33.13%7.61M | -67.27%700K | -61.32%3.88M | 148.60%260K | 1,185.49%2.77M | 9,823.08%11.38M | 7,230.00%2.14M | 34,675.86%10.03M | -1,744.83%-535K |
Proceeds from stock option exercised by employees | 31.30%1.23M | 55.30%9.69M | 791.68%4.4M | 465.55%2.02M | 53.64%2.34M | -75.86%933K | 98.22%6.24M | 1,725.93%493K | -15.60%357K | -39.24%1.53M |
Net other financing activities | 358,000.00%3.58M | 30.60%-1.74M | ---2K | 30.64%-1.73M | --1K | --1K | ---2.5M | --0 | ---2.5M | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 30.85%4.84M | 2.96%15.56M | 93.54%5.09M | -47.20%4.16M | 163.03%2.6M | 2.55%3.7M | 398.71%15.12M | 87,833.33%2.63M | 1,901.02%7.88M | -60.10%990K |
Net cash flow | ||||||||||
Beginning cash position | 52.52%86.16M | -27.99%56.49M | 51.96%97.29M | -16.74%76.87M | -24.58%58.31M | -27.99%56.49M | 47.54%78.45M | -12.13%64.03M | 39.25%92.32M | 32.81%77.32M |
Current changes in cash | -1,833.08%-31.54M | 234.88%29.61M | -48.40%-11.2M | 172.34%20.46M | 23.43%18.54M | 259.51%1.82M | -186.96%-21.95M | -234.90%-7.55M | -528.10%-28.28M | 87.10%15.02M |
Effect of exchange rate changes | ---233K | 690.00%59K | 366.67%70K | -52.38%-32K | 240.00%21K | --0 | -129.41%-10K | 475.00%15K | 52.27%-21K | -127.78%-15K |
End cash Position | -6.73%54.39M | 52.52%86.16M | 52.52%86.16M | 51.96%97.29M | -16.74%76.87M | -24.58%58.31M | -27.99%56.49M | -27.99%56.49M | -12.13%64.03M | 39.25%92.32M |
Free cash from | -2,301.97%-45.21M | 187.21%43.19M | 226.19%12.85M | 145.06%16.29M | 107.10%15.93M | 82.69%-1.88M | -364.47%-49.52M | -319.65%-10.18M | -818.48%-36.16M | 49.23%7.69M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.